In contrast, the knock-down of CSNK2A1 sensitized U2OS and KHOS/NP osteosarcoma cells to doxorubicin in the CCK8 assay and colony-forming assay (Figure 3c,d). This evidence concerns the gene CSNK2A1 and osteosarcoma.